ADRIENNE KEBODEAUX, a 10% owner of $GSHD, sold 3,000 shares of the company on 08-19-2025 for an estimated $258,900. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $GSHD stock.
$GSHD Insider Trading Activity
$GSHD insiders have traded $GSHD stock on the open market 61 times in the past 6 months. Of those trades, 2 have been purchases and 59 have been sales.
Here’s a breakdown of recent trading of $GSHD stock by insiders over the last 6 months:
- & ROBYN JONES DESCENDANTS TRUST 2014 MARK has made 0 purchases and 46 sales selling 591,770 shares for an estimated $59,474,333.
- THOMAS MCCONNON has made 0 purchases and 2 sales selling 205,000 shares for an estimated $24,875,730.
- MARK EVAN JONES (Executive Chairman) has made 0 purchases and 4 sales selling 40,000 shares for an estimated $4,761,433.
- LINDY LANGSTON has made 0 purchases and 3 sales selling 15,000 shares for an estimated $1,652,720.
- WADED CRUZADO has made 0 purchases and 2 sales selling 8,450 shares for an estimated $1,002,150.
- JOHN TERRY O'CONNOR (General Counsel) sold 2,500 shares for an estimated $261,050
- ADRIENNE KEBODEAUX sold 3,000 shares for an estimated $258,900
- MARK E. JR. JONES (Chief Financial Officer) has made 2 purchases buying 2,159 shares for an estimated $218,106 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$GSHD Hedge Fund Activity
We have seen 138 institutional investors add shares of $GSHD stock to their portfolio, and 163 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DURABLE CAPITAL PARTNERS LP added 680,812 shares (+inf%) to their portfolio in Q2 2025, for an estimated $71,832,474
- CIBC PRIVATE WEALTH GROUP LLC added 446,537 shares (+18406.3%) to their portfolio in Q2 2025, for an estimated $47,114,118
- WHITEBARK INVESTORS LP removed 339,008 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $35,768,734
- BALYASNY ASSET MANAGEMENT L.P. added 302,130 shares (+118.7%) to their portfolio in Q2 2025, for an estimated $31,877,736
- WASATCH ADVISORS LP added 253,777 shares (+12.6%) to their portfolio in Q2 2025, for an estimated $26,776,011
- 3G CAPITAL PARTNERS LP added 237,500 shares (+105.6%) to their portfolio in Q2 2025, for an estimated $25,058,625
- MARSHALL WACE, LLP removed 205,128 shares (-93.3%) from their portfolio in Q2 2025, for an estimated $21,643,055
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$GSHD Analyst Ratings
Wall Street analysts have issued reports on $GSHD in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 07/28/2025
- Keefe, Bruyette & Woods issued a "Outperform" rating on 07/24/2025
- JMP Securities issued a "Market Outperform" rating on 04/24/2025
- B of A Securities issued a "Underperform" rating on 02/25/2025
- Citizens Capital Markets issued a "Market Outperform" rating on 02/25/2025
To track analyst ratings and price targets for $GSHD, check out Quiver Quantitative's $GSHD forecast page.
$GSHD Price Targets
Multiple analysts have issued price targets for $GSHD recently. We have seen 9 analysts offer price targets for $GSHD in the last 6 months, with a median target of $110.0.
Here are some recent targets:
- Brian Meredith from UBS set a target price of $136.0 on 07/28/2025
- Michael Zaremski from BMO Capital set a target price of $110.0 on 07/25/2025
- Tommy McJoynt from Keefe, Bruyette & Woods set a target price of $120.0 on 07/24/2025
- Paul Newsome from Piper Sandler set a target price of $109.0 on 07/24/2025
- Pablo Singzon from JP Morgan set a target price of $98.0 on 04/24/2025
- Matthew Carletti from JMP Securities set a target price of $150.0 on 04/24/2025
- Joshua Shanker from B of A Securities set a target price of $43.0 on 02/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
